老年心衰患者心脏移植与长期机械支持的QALY比较:SUSTAIN-IT研究
SUSTAIN-IT研究纳入393例60-80岁心衰患者,161例接受心脏移植(68例移植前机械支持,93例无机械支持),144例接受长期机械支持。随访24个月,无移植前机械支持的心脏移植组QALY最高(22.58±1.1),显著高于移植前机械支持组(19.53±1.33)和长期机械支持组(19.49±1.3),p=0.003。
要点
- 无移植前机械支持的心脏移植组24个月QALY最高(22.58±1.1)。
- 移植前机械支持组与长期机械支持组QALY相近(19.53 vs 19.49)。
- 移植前机械支持、低LVEF、NYHA III-IV级等与QALY增益较低相关。
核心结论
- QALY的测定可为政策制定者和临床医生考虑心脏移植与长期机械支持作为老年心衰患者治疗选择的获益提供重要信息。
研究设计与样本
- 通过24个月随访收集生存和健康相关生活质量数据,QALY健康效用基于患者自报EQ-5D-3L维度,采用广义线性模型比较组间平均限制QALY。
主要发现
- 整个队列手术时平均年龄67岁(标准差4.7),78%为男性,83%为白人。
- 术后18个月起,各组调整后平均QALY出现持续显著差异,无移植前机械支持的心脏移植组平均QALY最高(24个月窗口:无移植前机械支持组=22.58±1.1,移植前机械支持组=19.53±1.33,长期机械支持组=19.49±1.3,p=0.003)。
- 术后24个月时,QALY增益较低与移植前机械支持、长期机械支持、较低的术前左心室射血分数、术前NYHA III或IV级以及缺血性或其他病因的心衰相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The quality-adjusted life year (QALY) measures disease burden and treatment, combining overall survival and health-related quality of life (HRQOL). We estimated QALYs in 3 groups of older patients (60-80 years) with heart failure (HF) who underwent heart transplantation (HT, with pre-transplant mechanical circulatory support [HT MCS] or HT without pre-transplant MCS [HT Non-MCS]) or long-term MCS (destination therapy). We also identified factors associated with gains in QALYs through 24 months follow-up. METHODS: Of 393 eligible patients enrolled (10/1/15-12/31/18) at 13 U.S. sites, 161 underwent HT (n = 68 HT MCS, n = 93 HT Non-MCS) and 144 underwent long-term MCS. Survival and HRQOL data were collected through 24 months. QALY health utilities were based on patient self-report of EQ-5D-3L dimensions. Mean-restricted QALYs were compared among groups using generalized linear models. RESULTS: For the entire cohort, mean age in years closest to surgery was 67 (standard deviation, SD: 4.7), 78% were male, and 83% were White. By 18 months post-surgery, sustained significant differences in adjusted average ± SD QALYs emerged across groups, with the HT Non-MCS group having the highest average QALYs (24-month window: HT Non-MCS = 22.58 ± 1.1, HT MCS = 19.53 ± 1.33, Long-term MCS = 19.49 ± 1.3, p = 0.003). At 24 months post-operatively, a lower gain in QALYs was associated with HT MCS, long-term MCS, a lower pre-operative LVEF, NYHA class III or IV before surgery, and an ischemic or other etiology of HF. CONCLUSIONS: Determination of QALYs may provide important information for policy makers and clinicians to consider regarding benefits of HT and long-term MCS as treatment options for older patients with HF.
引用
- Grady KL, Dew MA, Pagani FD, et al. A comparison of quality-adjusted life years in older adults after heart transplantation versus long-term mechanical support: Findings from the SUSTAIN-IT study. J Heart Lung Transplant. 2024. PMID: 38762215. doi:10.1016/j.healun.2024.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。